These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33296973)

  • 1. Demographic and clinical characterization of multiple sclerosis in Mexico: The REMEMBer study.
    Bertado-Cortés B; Venzor-Mendoza C; Rubio-Ordoñez D; Pérez-Pérez JR; Novelo-Manzano LA; Villamil-Osorio LV; Jiménez-Ortega MJ; Villalpando-Gueich ML; Sánchez-Rosales NA; García-Talavera V
    Mult Scler Relat Disord; 2020 Nov; 46():102575. PubMed ID: 33296973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes.
    Ciampi E; Uribe-San-Martin R; Soler B; Molnar K; Reyes D; Keller K; Carcamo C
    Mult Scler Relat Disord; 2020 Nov; 46():102565. PubMed ID: 33039942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic and clinical profile of Multiple Sclerosis in Kashmir: A short report.
    Zahoor I; Asimi R; Haq E; Yousuf Wani I
    Mult Scler Relat Disord; 2017 Apr; 13():103-106. PubMed ID: 28427689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics.
    Ghadiri F; Sahraian MA; Razazian N; Ashtari F; Poursadeghfard M; Nabavi SM; Navardi S; Baghbanian SM; Shaygannejad V; Harirchian MH; Beladimoghadam N; Majdinasab N; Hosseini S; Azimi A; Kamali H; Sharifipour E; Hosseini Nejad Mir N; Bayati A; Nahayati MA; Heidari H; Mozhdehipanah H; Ghalyanchi Langroodi H; Jalali N; Ayoubi S; Asadollahzadeh E; Ebadi Z; Eskandarieh S; Naser Moghadasi A
    Mult Scler Relat Disord; 2023 Feb; 70():104493. PubMed ID: 36638768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
    Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM
    Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study.
    Miclea A; Salmen A; Zoehner G; Diem L; Kamm CP; Chaloulos-Iakovidis P; Miclea M; Briner M; Kilidireas K; Stefanis L; Chan A; Evangelopoulos ME; Hoepner R
    CNS Neurosci Ther; 2019 Apr; 25(4):527-531. PubMed ID: 30411534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
    Sato S; Lim J; Miehm JD; Buonaccorsi J; Rajala C; Khalighinejad F; Ionete C; Kent JA; van Emmerik REA
    Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
    Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.
    Kantarci OH; Lebrun C; Siva A; Keegan MB; Azevedo CJ; Inglese M; Tintoré M; Newton BD; Durand-Dubief F; Amato MP; De Stefano N; Sormani MP; Pelletier D; Okuda DT
    Ann Neurol; 2016 Feb; 79(2):288-94. PubMed ID: 26599831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.
    Bergamaschi R; Beghi E; Bosetti C; Ponzio M; Santucci C; Lepore V; Mosconi P; ; Aguglia U; Amato MP; Ancona AL; Ardito B; Avolio C; Balgera R; Banfi P; Barcella V; Barone P; Bellantonio P; Berardinelli A; Bergamaschi R; Bertora P; Bianchi M; Bramanti P; Morra VB; Brichetto G; Brioschi AM; Buccafusca M; Bucello S; Busillo V; Calchetti B; Cantello R; Capobianco M; Capone F; Capone L; Cargnelutti D; Carrozzi M; Cartechini E; Cavaletti G; Cavalla P; Celani MG; Clerici R; Clerico M; Cocco E; Confalonieri P; Coniglio MG; Conte A; Corea F; Cottone S; Crociani P; D'Andrea F; Danni MC; De Luca G; de Pascalis D; De Riz M; De Robertis F; De Rosa G; De Stefano N; Corte MD; Di Sapio A; Docimo R; Falcini M; Falcone N; Fermi S; Ferraro E; Ferrò MT; Fortunato M; Foschi M; Gajofatto A; Gallo A; Gallo P; Gatto M; Gazzola P; Giordano A; Granella F; Grasso MF; Grasso MG; Grimaldi LME; Iaffaldano P; Imperiale D; Inglese M; Iodice R; Leva S; Luezzi V; Lugaresi A; Lus G; Maimone D; Mancinelli L; Maniscalco GT; Marfia GA; Marini B; Marson A; Mascoli N; Massacesi L; Melani F; Merello M; Meucci G; Mirabella M; Montepietra S; Nasuelli D; Nicolao P; Passantino F; Patti F; Peresson M; Pesci I; Piantadosi C; Piras ML; Pizzorno M; Plewnia K; Pozzilli C; Protti A; Quatrale R; Realmuto S; Ribizzi G; Rinalduzzi S; Rini A; Romano S; Romeo M; Ronzoni M; Rossi P; Rovaris M; Salemi G; Santangelo G; Santangelo M; Santuccio G; Sarchielli P; Sinisi L; Sola P; Solaro C; Spitaleri D; Strumia S; Tassinari T; Tonietti S; Tortorella C; Totaro R; Tozzo A; Trivelli G; Ulivelli M; Valentino P; Venturi S; Vianello M; Zaffaroni M; Zarbo R; Trojano M; Battaglia MA; Capobianco M; Pugliatti M; Ulivelli M; Mosconi P; Gasperini C; Patti F; Amato MP; Bergamaschi R; Comi G
    Neurol Sci; 2022 Sep; 43(9):5459-5469. PubMed ID: 35672479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
    Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
    BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.
    Kerbrat A; Hamonic S; Leray E; Tron I; Edan G; Yaouanq J;
    Eur J Neurol; 2015 Mar; 22(3):507-e35. PubMed ID: 25515927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
    Sinnecker T; Clarke MA; Meier D; Enzinger C; Calabrese M; De Stefano N; Pitiot A; Giorgio A; Schoonheim MM; Paul F; Pawlak MA; Schmidt R; Kappos L; Montalban X; Rovira À; Evangelou N; Wuerfel J;
    JAMA Neurol; 2019 Dec; 76(12):1446-1456. PubMed ID: 31424490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of multiple sclerosis in Sardinia: A systematic cross-sectional multi-source survey.
    Urru SA; Antonelli A; Sechi GM;
    Mult Scler; 2020 Mar; 26(3):372-380. PubMed ID: 30793660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis in Jordan: A clinical and epidemiological study.
    El-Salem K; Al-Shimmery E; Horany K; Al-Refai A; Al-Hayk K; Khader Y
    J Neurol; 2006 Sep; 253(9):1210-6. PubMed ID: 16649096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological study of multiple sclerosis in La Rioja.
    Bártulos Iglesias M; Marzo Sola ME; Estrella Ruiz LA; Bravo Anguiano Y
    Neurologia; 2015; 30(9):552-60. PubMed ID: 24975346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
    Roshanisefat H; Bahmanyar S; Hillert J; Olsson T; Montgomery S
    Eur J Neurol; 2014 Nov; 21(11):1353-e88. PubMed ID: 25041631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.